These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 21793041)

  • 1. High CJD infectivity remains after prion protein is destroyed.
    Miyazawa K; Emmerling K; Manuelidis L
    J Cell Biochem; 2011 Dec; 112(12):3630-7. PubMed ID: 21793041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly infectious CJD particles lack prion protein but contain many viral-linked peptides by LC-MS/MS.
    Kipkorir T; Tittman S; Botsios S; Manuelidis L
    J Cell Biochem; 2014 Nov; 115(11):2012-21. PubMed ID: 24933657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CJD and Scrapie Require Agent-Associated Nucleic Acids for Infection.
    Botsios S; Manuelidis L
    J Cell Biochem; 2016 Aug; 117(8):1947-58. PubMed ID: 26773845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure to detect the presence of prions in the uterine and gestational tissues from a Gravida with Creutzfeldt-Jakob disease.
    Xiao X; Miravalle L; Yuan J; McGeehan J; Dong Z; Wyza R; MacLennan GT; Golichowski AM; Kneale G; King N; Kong Q; Spina S; Vidal R; Ghetti B; Roos K; Gambetti P; Zou WQ
    Am J Pathol; 2009 May; 174(5):1602-8. PubMed ID: 19349373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prion infectivity is encoded exclusively within the structure of proteinase K-resistant fragments of synthetically generated recombinant PrP
    Wang F; Wang X; Abskharon R; Ma J
    Acta Neuropathol Commun; 2018 Apr; 6(1):30. PubMed ID: 29699569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two Creutzfeldt-Jakob disease agents reproduce prion protein-independent identities in cell cultures.
    Arjona A; Simarro L; Islinger F; Nishida N; Manuelidis L
    Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8768-73. PubMed ID: 15161970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transmission characteristics of heterozygous cases of Creutzfeldt-Jakob disease with variable abnormal prion protein allotypes.
    Ward A; Hollister JR; McNally K; Ritchie DL; Zanusso G; Priola SA
    Acta Neuropathol Commun; 2020 Jun; 8(1):83. PubMed ID: 32517816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Subtyping of PrP
    Klug GM; Lewis V; Collins SJ
    Methods Mol Biol; 2017; 1658():347-354. PubMed ID: 28861800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond PrP9res) type 1/type 2 dichotomy in Creutzfeldt-Jakob disease.
    Uro-Coste E; Cassard H; Simon S; Lugan S; Bilheude JM; Perret-Liaudet A; Ironside JW; Haik S; Basset-Leobon C; Lacroux C; Peoch' K; Streichenberger N; Langeveld J; Head MW; Grassi J; Hauw JJ; Schelcher F; Delisle MB; Andréoletti O
    PLoS Pathog; 2008 Mar; 4(3):e1000029. PubMed ID: 18389084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous production of prions after infectious particles are eliminated: implications for Alzheimer's disease.
    Miyazawa K; Kipkorir T; Tittman S; Manuelidis L
    PLoS One; 2012; 7(4):e35471. PubMed ID: 22509412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic wasting disease of elk and deer and Creutzfeldt-Jakob disease: comparative analysis of the scrapie prion protein.
    Xie Z; O'Rourke KI; Dong Z; Jenny AL; Langenberg JA; Belay ED; Schonberger LB; Petersen RB; Zou W; Kong Q; Gambetti P; Chen SG
    J Biol Chem; 2006 Feb; 281(7):4199-206. PubMed ID: 16338930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A refined method for molecular typing reveals that co-occurrence of PrP(Sc) types in Creutzfeldt-Jakob disease is not the rule.
    Notari S; Capellari S; Langeveld J; Giese A; Strammiello R; Gambetti P; Kretzschmar HA; Parchi P
    Lab Invest; 2007 Nov; 87(11):1103-12. PubMed ID: 17893675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prions from Sporadic Creutzfeldt-Jakob Disease Patients Propagate as Strain Mixtures.
    Cassard H; Huor A; Espinosa JC; Douet JY; Lugan S; Aron N; Vilette D; Delisle MB; Marín-Moreno A; Peran P; Beringue V; Torres JM; Ironside JW; Andreoletti O
    mBio; 2020 Jun; 11(3):. PubMed ID: 32546613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular classification of sporadic Creutzfeldt-Jakob disease.
    Hill AF; Joiner S; Wadsworth JD; Sidle KC; Bell JE; Budka H; Ironside JW; Collinge J
    Brain; 2003 Jun; 126(Pt 6):1333-46. PubMed ID: 12764055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic analysis of host brain components that bind to infectious particles in Creutzfeldt-Jakob disease.
    Kipkorir T; Colangelo CM; Manuelidis L
    Proteomics; 2015 Sep; 15(17):2983-98. PubMed ID: 25930988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prion protein accumulation in eyes of patients with sporadic and variant Creutzfeldt-Jakob disease.
    Head MW; Northcott V; Rennison K; Ritchie D; McCardle L; Bunn TJ; McLennan NF; Ironside JW; Tullo AB; Bonshek RE
    Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):342-6. PubMed ID: 12506094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early appearance but lagged accumulation of detergent-insoluble prion protein in the brains of mice inoculated with a mouse-adapted Creutzfeldt-Jakob disease agent.
    Nakaoke R; Sakaguchi S; Atarashi R; Nishida N; Arima K; Shigematsu K; Katamine S
    Cell Mol Neurobiol; 2000 Dec; 20(6):717-30. PubMed ID: 11100979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 25 nm virion is the likely cause of transmissible spongiform encephalopathies.
    Manuelidis L
    J Cell Biochem; 2007 Mar; 100(4):897-915. PubMed ID: 17044041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of novel proteinase K-resistant C-terminal fragments of PrP in Creutzfeldt-Jakob disease.
    Zou WQ; Capellari S; Parchi P; Sy MS; Gambetti P; Chen SG
    J Biol Chem; 2003 Oct; 278(42):40429-36. PubMed ID: 12917418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexistence of multiple PrPSc types in individuals with Creutzfeldt-Jakob disease.
    Polymenidou M; Stoeck K; Glatzel M; Vey M; Bellon A; Aguzzi A
    Lancet Neurol; 2005 Dec; 4(12):805-14. PubMed ID: 16297838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.